Side effects of long acting cholinesterase inhibitors
- 29 January 2009
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 88 (S149) , 53-54
- https://doi.org/10.1111/j.1600-0404.1993.tb04256.x
Abstract
This paper reviews the side effects of the two long acting cholinesterase inhibitors tacrine and velnacrine. It will focus on tacrine which has been most studied. The two drugs are special as the dosage of them is guided mainly by side effects and not by therapeutic effects in contrast to most drugs used for psychiatric disorders.Keywords
This publication has 5 references indexed in Scilit:
- A Controlled Trial of Tacrine in Alzheimer's DiseaseJAMA, 1992
- Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's DiseaseaAnnals of the New York Academy of Sciences, 1991
- Tacrine in Alzheimer's diseasePublished by Elsevier ,1991
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine.BMJ, 1990